 CAMBRIDGE, Mass.--BUSINESS WIRE--- AVRO--AVROBIO, Inc. Nasdaq: AVRO, a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that members of its senior management team are scheduled to participate in four upcoming virtual investor conferences. Citis 16th Annual BioPharma Virtual Conference Date: Wednesday, Sept. 8 - Friday, Sept. 10, 2021 1x1 meetings only 2021 Wells Fargo Virtual Healthcare Conference Presentation date: Thurs 